158 related articles for article (PubMed ID: 32993136)
1. Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning.
Ackerman EE; Shoemaker JE
Viruses; 2020 Sep; 12(10):. PubMed ID: 32993136
[TBL] [Abstract][Full Text] [Related]
2. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Gordon DE; Jang GM; Bouhaddou M; Xu J; Obernier K; White KM; O'Meara MJ; Rezelj VV; Guo JZ; Swaney DL; Tummino TA; Hüttenhain R; Kaake RM; Richards AL; Tutuncuoglu B; Foussard H; Batra J; Haas K; Modak M; Kim M; Haas P; Polacco BJ; Braberg H; Fabius JM; Eckhardt M; Soucheray M; Bennett MJ; Cakir M; McGregor MJ; Li Q; Meyer B; Roesch F; Vallet T; Mac Kain A; Miorin L; Moreno E; Naing ZZC; Zhou Y; Peng S; Shi Y; Zhang Z; Shen W; Kirby IT; Melnyk JE; Chorba JS; Lou K; Dai SA; Barrio-Hernandez I; Memon D; Hernandez-Armenta C; Lyu J; Mathy CJP; Perica T; Pilla KB; Ganesan SJ; Saltzberg DJ; Rakesh R; Liu X; Rosenthal SB; Calviello L; Venkataramanan S; Liboy-Lugo J; Lin Y; Huang XP; Liu Y; Wankowicz SA; Bohn M; Safari M; Ugur FS; Koh C; Savar NS; Tran QD; Shengjuler D; Fletcher SJ; O'Neal MC; Cai Y; Chang JCJ; Broadhurst DJ; Klippsten S; Sharp PP; Wenzell NA; Kuzuoglu-Ozturk D; Wang HY; Trenker R; Young JM; Cavero DA; Hiatt J; Roth TL; Rathore U; Subramanian A; Noack J; Hubert M; Stroud RM; Frankel AD; Rosenberg OS; Verba KA; Agard DA; Ott M; Emerman M; Jura N; von Zastrow M; Verdin E; Ashworth A; Schwartz O; d'Enfert C; Mukherjee S; Jacobson M; Malik HS; Fujimori DG; Ideker T; Craik CS; Floor SN; Fraser JS; Gross JD; Sali A; Roth BL; Ruggero D; Taunton J; Kortemme T; Beltrao P; Vignuzzi M; García-Sastre A; Shokat KM; Shoichet BK; Krogan NJ
Nature; 2020 Jul; 583(7816):459-468. PubMed ID: 32353859
[TBL] [Abstract][Full Text] [Related]
3. Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease.
Tsuji M
FEBS Open Bio; 2020 Jun; 10(6):995-1004. PubMed ID: 32374074
[TBL] [Abstract][Full Text] [Related]
4. Repurposing existing drugs for COVID-19: an endocrinology perspective.
Cadegiani FA
BMC Endocr Disord; 2020 Sep; 20(1):149. PubMed ID: 32993622
[TBL] [Abstract][Full Text] [Related]
5. Tackling SARS-CoV-2: proposed targets and repurposed drugs.
Joshi S; Joshi M; Degani MS
Future Med Chem; 2020 Sep; 12(17):1579-1601. PubMed ID: 32564623
[TBL] [Abstract][Full Text] [Related]
6. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
Sadegh S; Matschinske J; Blumenthal DB; Galindez G; Kacprowski T; List M; Nasirigerdeh R; Oubounyt M; Pichlmair A; Rose TD; Salgado-Albarrán M; Späth J; Stukalov A; Wenke NK; Yuan K; Pauling JK; Baumbach J
Nat Commun; 2020 Jul; 11(1):3518. PubMed ID: 32665542
[TBL] [Abstract][Full Text] [Related]
7. Boosting the arsenal against COVID-19 through computational drug repurposing.
Ciliberto G; Cardone L
Drug Discov Today; 2020 Jun; 25(6):946-948. PubMed ID: 32304645
[No Abstract] [Full Text] [Related]
8. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
Ugurel OM; Mutlu O; Sariyer E; Kocer S; Ugurel E; Inci TG; Ata O; Turgut-Balik D
Int J Biol Macromol; 2020 Nov; 163():1687-1696. PubMed ID: 32980406
[TBL] [Abstract][Full Text] [Related]
9. Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19.
Hage-Melim LIDS; Federico LB; de Oliveira NKS; Francisco VCC; Correia LC; de Lima HB; Gomes SQ; Barcelos MP; Francischini IAG; da Silva CHTP
Life Sci; 2020 Sep; 256():117963. PubMed ID: 32535080
[TBL] [Abstract][Full Text] [Related]
10. Potential Unconventional Medicines for the Treatment of SARS-CoV-2.
Coppola M; Mondola R
Drug Res (Stuttg); 2020 Jun; 70(6):286. PubMed ID: 32428941
[No Abstract] [Full Text] [Related]
11. Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges.
Parvathaneni V; Gupta V
Life Sci; 2020 Oct; 259():118275. PubMed ID: 32818545
[TBL] [Abstract][Full Text] [Related]
12. Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
Arshad U; Pertinez H; Box H; Tatham L; Rajoli RKR; Curley P; Neary M; Sharp J; Liptrott NJ; Valentijn A; David C; Rannard SP; O'Neill PM; Aljayyoussi G; Pennington SH; Ward SA; Hill A; Back DJ; Khoo SH; Bray PG; Biagini GA; Owen A
Clin Pharmacol Ther; 2020 Oct; 108(4):775-790. PubMed ID: 32438446
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: molecular targets, drug repurposing and new avenues for drug discovery.
Senger MR; Evangelista TCS; Dantas RF; Santana MVDS; Gonçalves LCS; de Souza Neto LR; Ferreira SB; Silva-Junior FP
Mem Inst Oswaldo Cruz; 2020; 115():e200254. PubMed ID: 33027420
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements.
Pandey A; Nikam AN; Shreya AB; Mutalik SP; Gopalan D; Kulkarni S; Padya BS; Fernandes G; Mutalik S; Prassl R
Life Sci; 2020 Sep; 256():117883. PubMed ID: 32497632
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19).
Rameshrad M; Ghafoori M; Mohammadpour AH; Nayeri MJD; Hosseinzadeh H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1137-1152. PubMed ID: 32430617
[TBL] [Abstract][Full Text] [Related]
16. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
[TBL] [Abstract][Full Text] [Related]
17. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-Encoded Proteome and Human Genetics: From Interaction-Based to Ribosomal Biology Impact on Disease and Risk Processes.
Sirpilla O; Bauss J; Gupta R; Underwood A; Qutob D; Freeland T; Bupp C; Carcillo J; Hartog N; Rajasekaran S; Prokop JW
J Proteome Res; 2020 Nov; 19(11):4275-4290. PubMed ID: 32686937
[TBL] [Abstract][Full Text] [Related]
19. Synthetic repurposing of drugs against hypertension: a datamining method based on association rules and a novel discrete algorithm.
Masoudi-Sobhanzadeh Y; Masoudi-Nejad A
BMC Bioinformatics; 2020 Jul; 21(1):313. PubMed ID: 32677879
[TBL] [Abstract][Full Text] [Related]
20. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
Mousavi SZ; Rahmanian M; Sami A
Infect Genet Evol; 2020 Dec; 86():104610. PubMed ID: 33130005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
